SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 28-Feb-24 | Payment of Exercise | 460 | $27.94 | $12,852.40 | (6%) 8.24K to 7.78K | |
29-Feb-24 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 28-Feb-24 | Option Exercise | 990 | -- | -- | 14% 7.25K to 8.24K | |
27-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Grant | 1,875 | -- | -- | 30% 6.31K to 8.19K | |
27-Feb-24 5:02 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 23-Feb-24 | Payment of Exercise | 937 | $29.06 | $27,229.20 | (11%) 8.19K to 7.25K | |
26-Feb-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Grant | 750 | -- | -- | 13% 5.9K to 6.65K | |
26-Feb-24 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-24 | Payment of Exercise | 335 | $27.94 | $9,359.90 | (5%) 6.65K to 6.31K | |
16-Nov-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 14-Nov-23 | Option Exercise | 2,000 | $9.24 | $18,480.00 | 42% 4.79K to 6.79K | |
16-Nov-23 5:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 14-Nov-23 | Option Sale | 1,110 | $28.13 | $31,224.30 | (16%) 6.79K to 5.68K | |
16-Mar-23 10:00 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 14-Mar-23 | Private Sale | 4,780 | $35.99 | $172,023.00 | (50%) 9.52K to 4.74K | |
24-Feb-23 5:01 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 22-Feb-23 | Grant | 750 | -- | -- | 9% 8.77K to 9.52K | |
21-Feb-23 5:35 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 16-Feb-23 | Payment of Exercise | 753 | $38.74 | $29,171.20 | (8%) 8.94K to 8.19K | |
21-Feb-23 5:35 PM View: | Supernus Pharmaceuticals, I... (SUPN) | 16-Feb-23 | Option Exercise | 1,500 | -- | -- | 20% 7.44K to 8.94K |